Mestastop gets a 2.66 Cr grant from BIRAC for extending its proprietary drug discovery models into oral and breast cancer
Mestastop Solutions, a biotech company focused on stopping the spread of cancer, has been awarded a 2.66 Cr grant by BIRAC under the focused call of “establishment of preclinical models …